Follow
Mehdi Tehrani-Doost
Mehdi Tehrani-Doost
Professor of Psychiatry, Tehran University of Medical Sciences
Verified email at sina.tums.ac.ir - Homepage
Title
Cited by
Cited by
Year
Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder
S Jazayeri, M Tehrani-Doost, SA Keshavarz, M Hosseini, A Djazayery, ...
Australian & New Zealand Journal of Psychiatry 42 (3), 192-198, 2008
3002008
The effects of probiotics on mental health and hypothalamic–pituitary–adrenal axis: A randomized, double-blind, placebo-controlled trial in petrochemical workers
AA Mohammadi, S Jazayeri, K Khosravi-Darani, Z Solati, ...
Nutritional neuroscience 19 (9), 387-395, 2016
2482016
Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder
N Khoraminya, M Tehrani-Doost, S Jazayeri, A Hosseini, A Djazayery
Australian & New Zealand Journal of Psychiatry 47 (3), 271-275, 2013
1702013
Prevalence of obsessive-compulsive disorder in Iran
MR Mohammadi, A Ghanizadeh, M Rahgozar, AA Noorbala, H Davidian, ...
BMC psychiatry 4 (1), 1-8, 2004
1462004
Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder
S Jazayeri, SA Keshavarz, M Tehrani-Doost, M Djalali, M Hosseini, ...
Psychiatry Research 178 (1), 112-115, 2010
1182010
subclinical hypothyroidism in pregnancy: Intellectual development of offspring
F behrooz, H.G., Tohidi, M., Mehrabi, Y., Behrooz, E.G., Tehranidoost, M., Azizi
Thyroid 21 (10), 1143-1147, 2011
1162011
Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double‐blind, randomized, placebo‐controlled trial
S Akhondzadeh, MR Milajerdi, H Amini, M Tehrani‐Doost
Bipolar disorders 8 (5p1), 485-489, 2006
952006
Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized …
Z Solati, S Jazayeri, M Tehrani-Doost, S Mahmoodianfard, MR Gohari
Nutritional neuroscience 18 (4), 162-168, 2015
902015
The reliability and validity of kiddie‐schedule for affective disorders and schizophrenia‐present and life‐time version‐Persian version
Z Shahrivar, M Kousha, S Moallemi, M Tehrani‐Doost, J Alaghband‐Rad
Child and Adolescent Mental Health 15 (2), 97-102, 2010
662010
Cyproheptadine in the treatment of autistic disorder: a double‐blind placebo‐controlled trial
S Akhondzadeh, S Erfani, MR Mohammadi, M Tehrani‐Doost, H Amini, ...
Journal of clinical pharmacy and therapeutics 29 (2), 145-150, 2004
602004
Normative data and psychometric properties of the child behavior checklist and teacher rating form in an Iranian community sample
M Tehrani-Doost, Z Shahrivar, B Pakbaz, A Rezaie, F Ahmadi
Iranian journal of pediatrics 21 (3), 331, 2011
592011
Normative data and psychometric properties of the parent and teacher versions of the strengths and difficulties questionnaire (SDQ) in an Iranian community sample
Z Shahrivar, M Tehrani-Doost, B Pakbaz, A Rezaie, F Ahmadi
Journal of research in medical sciences: the official journal of Isfahan …, 2009
552009
Toxoplasma infection in schizophrenia patients: a comparative study with control group
H Alipour, A., Shojaee, S., Mohebali, M., Tehranidoost, M., Abdi Masoleh, F ...
iranian Journal of Parasitology 6 (2), 31-37, 2011
542011
Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: a randomized, double blind, placebo-controlled trial
N Mohammadpour, S Jazayeri, M Tehrani-Doost, M Djalali, M Hosseini, ...
Nutritional neuroscience 21 (3), 202-209, 2018
512018
Effects of probiotics on biomarkers of oxidative stress and inflammatory factors in petrochemical workers: a randomized, double-blind, placebo-controlled trial
AA Mohammadi, S Jazayeri, K Khosravi-Darani, Z Solati, ...
International journal of preventive medicine 6, 2015
492015
selegiline in comparison with methylphenidate in attention deficit/hyperactivity disorder children and adolescents in a double-blind randomized clinical trial
H mohammadi, M.R., Ghanizadeh, A., Alaghband-Rad, j., Tehranidoost,M ...
Journal of Child and Adolescent Psychopharmacology 14 (3), 418-423, 2004
492004
Executive dysfunction in treated phenylketonuric patients
B Azadi, A Seddigh, M Tehrani-Doost, J Alaghband-Rad, MR Ashrafi
European child & adolescent psychiatry 18 (6), 360-368, 2009
482009
Prevalence of psychiatric disorders amongst adolescents in Tehran
Z Shahrivar, J Mahmoodi, A Alavi, MR Mohammadi, M Tehranidoost, ...
Iranian Journal of Psychiatry 3 (3), 100-104, 2008
422008
Using non-linear features of EEG for ADHD/normal participants’ classification
F Ghassemi, M Hassan_Moradi, M Tehrani-Doost, V Abootalebi
Procedia-Social and Behavioral Sciences 32, 148-152, 2012
402012
Validity of farsi version of strengths and difficulties questionnaire (SDQ)
DM TEHRANI, Z Shahrivar, BAZB PAK, A Rezaei, F Ahmadi
Advances in Cognitive Science 8 (432), 33-39, 2007
382007
The system can't perform the operation now. Try again later.
Articles 1–20